247 related articles for article (PubMed ID: 33961152)
41. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
42. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
[TBL] [Abstract][Full Text] [Related]
43. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma.
Kim S; Ki CS; Kim KM; Lee MG; Kim S; Bae JM; Kim JW
BMB Rep; 2011 Nov; 44(11):725-9. PubMed ID: 22118538
[TBL] [Abstract][Full Text] [Related]
44. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.
Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG
Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207
[TBL] [Abstract][Full Text] [Related]
45. Low expression of E-Cadherin and
García-Ruvalcaba A; Vázquez-Ibarra KC; Magaña-Torres MT; Rizo de-la-Torre LDC; Meléndez-Aranda L; López-Armas G; Cruz-Ramos JA; Peregrina-Sandoval J; Espinoza-Jiménez E; Rosales-Gradilla ME; Sánchez-López JY
Rev Invest Clin; 2023 Feb; 75(1):037-044. PubMed ID: 36652613
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
47. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
[TBL] [Abstract][Full Text] [Related]
48. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
[TBL] [Abstract][Full Text] [Related]
49. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
50. Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations.
Ladabaum U; Ford JM; Poultsides G; Norton J
Gastrointest Endosc; 2021 Dec; 94(6):1146-1147. PubMed ID: 34416278
[No Abstract] [Full Text] [Related]
51. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
[TBL] [Abstract][Full Text] [Related]
52. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
53. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
54. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
Zhang Q; Yang Z; Karamchandani DM
Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
[TBL] [Abstract][Full Text] [Related]
55. Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation.
Kim HJ; Kim N; Kim HW; Park JH; Shin CM; Lee DH
Gastric Cancer; 2021 Mar; 24(2):302-313. PubMed ID: 32915372
[TBL] [Abstract][Full Text] [Related]
56. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
57. Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
Mizuguchi A; Takai A; Shimizu T; Matsumoto T; Kumagai K; Miyamoto S; Seno H; Marusawa H
Int J Cancer; 2018 Oct; 143(8):1923-1934. PubMed ID: 29717480
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
[TBL] [Abstract][Full Text] [Related]
59. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
60. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diffuse gastric cancer patient with a
Namikawa K; Kawachi H; Tsugeno Y; Nakajima T; Fujisaki J
VideoGIE; 2021 Apr; 6(4):163-166. PubMed ID: 33898891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
